Texas is currently home to 5027 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Houston, Dallas, San Antonio and Austin. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
CSD201001: Study to Assess Elements of Abuse Liability for Three Nicotine Pouches
Recruiting
This is a two-site, open-label, randomized, 5-way cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics [PD]) and plasma nicotine uptake (pharmacokinetics [PK]) during and following ad libitum use of the study investigational products (IPs) by generally healthy smokers.
Gender:
All
Ages:
Between 21 years and 60 years
Trial Updated:
06/23/2022
Locations: ICON Clinical Research, San Antonio, Texas
Conditions: Smoking, Tobacco Use, Tobacco Smoking
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy
Recruiting
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab and rituximab plus chemotherapy or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Gender:
All
Ages:
All
Trial Updated:
06/23/2022
Locations: Baylor Scott and White Research Institute (Adults only), Dallas, Texas
Conditions: Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant, Stem Cell Transplant Complications
Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury
Recruiting
The DOOR SCI project examines dosing effects of robotic gait training (RGT) and transcranial magnetic stimulation (TMS) initiated during inpatient rehabilitation and continued through early outpatient rehabilitation
Gender:
All
Ages:
Between 16 years and 85 years
Trial Updated:
06/20/2022
Locations: Baylor Scott & White Institute for Rehabilitation, Dallas, Texas
Conditions: Spinal Cord Injuries
Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting
Recruiting
The objective of this pivotal study is to evaluate the safety and efficacy of the CGuard™ Carotid Stent System in the treatment of carotid artery stenosis in symptomatic and asymptomatic patients undergoing carotid artery stenting (CAS) to a performance goal developed from published CAS literature.
Gender:
All
Ages:
Between 19 years and 80 years
Trial Updated:
06/16/2022
Locations: Ascension Seton, Seton Heart Institute, Austin, Texas
Conditions: Carotid Artery Stenosis
Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study
Recruiting
This study investigates if a new type of test called Droplet-BC screening test can classify breast cancer patients from non-cancer volunteers by circulating small-noncoding RNA in the blood with a statistical validity. This study also investigates if this test can classify the subgroup of breast cancer patients with a variety of conditions. Information from this study may provide a new method of breast cancer screening/diagnosis
Gender:
All
Ages:
18 years and above
Trial Updated:
06/15/2022
Locations: M D Anderson Cancer Center, Houston, Texas
Conditions: Breast Carcinoma
Fetoscopic NEOX Cord 1K® Spina Bifida Repair
Recruiting
To fetoscopically use cryopreserved human umbilical cord allografts, named NEOX Cord 1K®, as a spinal cord cover of spina bifida defects. This procedure will be performed to create a watertight seal covering over the spinal cord in order to decrease the incidence rates of postnatal morbidities. For larger skin defects, NEOX Cord 1K® may be used as a skin cover.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/14/2022
Locations: The University of Texas Health Science Center at Houston, Houston, Texas
Conditions: Spina Bifida, Myelomeningocele, Myeloschisis
CATCH Healthy Smiles:An Elementary School Oral Health Intervention Trial
Recruiting
The purpose of this study is to clinically evaluate the effects of a school-based behavioral intervention, CATCH Healthy Smiles, to reduce the risk of dental caries in a cohort of kindergarten through 2nd grade (K-2) children serving low-income, ethnically-diverse children,to determine the impact of CATCH Healthy Smiles on child behavioral, psychosocial, and environmental outcomes beginning in K through 2nd grade, compared to children in the control schools and to examine the extent to which the... Read More
Gender:
All
Ages:
Between 5 years and 9 years
Trial Updated:
06/09/2022
Locations: The University of Texas Health Science Center at Houston, Houston, Texas
Conditions: Caries,Dental
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
Recruiting
This randomized phase II trial studies how well obinutuzumab works as maintenance treatment in patients with central nervous system lymphoma who have achieved the disappearance of all signs of cancer in response to treatment (complete response) or a decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment (partial response). Immunotherapy with obinutuzumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to gro... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/09/2022
Locations: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Conditions: Central Nervous System B-Cell Non-Hodgkin Lymphoma
Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
Recruiting
Acute stroke afflicts nearly 700,000 patients in the US and is the number 3 cause of death. Only 2-9% of this large number is treated with t-PA if they arrive within 4.5 hours. An equally small percentage of patients with large vessel occlusion undergo thrombectomy. The thrombectomy patients may or may not receive t-PA. Some of these patients rarely receive intravenous GPIIB/IIIa inhibitors. Many lines of evidence suggest that GP IIb/IIIa inhibitors, a class of FDA approved potent platelet inhi... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/08/2022
Locations: Michael E. DeBakey VA Medical Center, Houston, Texas
Conditions: Acute Ischemic Stroke
Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
Recruiting
This is a first-in-human (FIH), multicenter, open-label Phase I dose escalation study to evaluate the safety and preliminary efficacy of the TT-01488 tablet, a non-covalent reversible BTK inhibitor, for the treatment of adult patients with B-cell malignancies.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/08/2022
Locations: The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas
Conditions: B-Cell Malignancies
Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
Recruiting
This protocol is a blinded randomized controlled study of the effects of BB-12 with LGG at different doses in 70 healthy children with autism spectrum disorders at lower and higher doses over an 56-day period and a 28- day observation period. The study is being conducted in order to assess safety and tolerability of the probiotic (BB-12 with LGG) at 2 different doses of BB-12 with LGG. Identifying effects on behaviors in healthy children with ASD using SRS-2 and ABC, GI symptoms using GI symptom... Read More
Gender:
All
Ages:
Between 4 years and 16 years
Trial Updated:
06/08/2022
Locations: UTHealth, Houston, Texas
Conditions: Autism Spectrum Disorder, Gastrointestinal Symptoms
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
Recruiting
A high prevalence of diabetes has been reported in Qatar with nearly 23% population suffering from the pandemic, thereby increasing the associated healthcare cost. Low compliance with exercise and physical activity in patients with diabetes increases foot risk complications, deteriorates health, and further increases economic costs. This is particularly true among patients with diabetes who are undergoing hemodialysis (HD) process. Exercise interventions have been shown to improve mobility and b... Read More
Gender:
All
Ages:
40 years and above
Trial Updated:
06/02/2022
Locations: Baylor College of Medicine, USA, Houston, Texas
Conditions: Diabetes Mellitus, Hemodialysis Complication, Cardiovascular Complication, Quality of Life